10 October 2020 - The company behind President Donald Trump’s last hope for a vaccine by Election Day has quietly begun courting influential health experts, including some of its toughest critics, to head off charges that it's moving too fast in the face of intense political pressure.
The campaign by Pfizer comes amid growing scrutiny of CEO Albert Bourla’s predictions that the company will know this month whether it has a viable vaccine — making it the only major vaccine developer that says it could know whether its shot works by 3 November.
And even though chances are slim that the company can meet the Food and Drug Administration’s tough new standards for vaccine safety data by that date, Bourla hasn’t backed down.